AMA Webinar: FDA Review Process for COVID-19 Vaccine Candidates (Episode 1 of a series)

Join AMA President, Susan R. Bailey, MD and Peter Marks, MD, PhD, Director of the Center for Biologics Evaluation and Research at the Food and Drug Administration (FDA) for a comprehensive overview of the FDA vaccine review process, including what the process looks like for COVID-19 vaccine candidates and the differences between the Emergency Use Authorization (EUA) and Biologic License Application (BLA) pathways. Episode 2 airs on Oct. 13.

[billyjobs]

Biologics Evaluation and Research at the Food and Drug Administration (FDA) for a comprehensive overview of the FDA vaccine review process, including what the process looks like for COVID-19 vaccine candidates and the differences between the Emergency Use Authorization (EUA) and Biologic License Application (BLA) pathways. Episode 2 airs on Oct. 13.

[angleeyes]

Povide drug papers of ingredients and side affects.I don't see how drug store and doctors can legally feel good about giving a drug no one knows what all is in it or the side affects that is killing people who is having reacts from these vacines.

[financereform]

take the hold off of Inovio and you'll have your T-cells

[wanyjoseph]

Biologics Evaluation and Research at the Food and Drug Administration (FDA) for a comprehensive overview of the FDA vaccine review process, including what the process looks like for COVID-19 vaccine candidates and the differences between the Emergency Use Authorization (EUA) and Biologic License Application (BLA) pathways. Episode 2 airs on Oct. 13.